Transpact Enterprises Share Price

BSE
TRANSPACT •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Transpact Enterprises
Transpact Enterprises Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Transpact Enterprises Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
51.50% Fall from 52W High
-1.6
Dividend yield 1yr %
0

Transpact Enterprises shareholding Pattern

Promoter
16.2%
Public
83.8%
Promoter
18.2%
Public
81.8%
Promoter
32.2%
Public
67.8%

Transpact Enterprises Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
12
Bearish Moving Averages
4
5Day EMA
186.30
10Day EMA
178.60
12Day EMA
176.90
20Day EMA
174.90
26Day EMA
176.20
50Day EMA
185.30
100Day EMA
202.20
200Day EMA
207.60
5Day SMA
189.10
10Day SMA
174.50
20Day SMA
163.60
30Day SMA
170.30
50Day SMA
192.50
100Day SMA
191.90
150Day SMA
241.20
200Day SMA
241.30
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
2000 Rs
2000 Rs
Week Rs
2750 Rs
2750 Rs
Month Rs
null Rs
null Rs
Resistance & Support
194.33
Pivot
Resistance
First Resistance
194.67
Second Resistance
195.33
Third Resistance
195.67
Support
First Support
193.67
Second support
193.33
Third Support
192.67
Relative Strength Index
58.09
Money Flow Index
88.36
MACD
0.67
MACD Signal
-5.48
Average True Range
12.74
Average Directional Index
23.38
Rate of Change (21)
16.94
Rate of Change (125)
-40.46

Transpact Enterprises Company background

Founded in: 2013
Managing director: Aslam Khan
Transpact Enterprises Limited was incorporated as a Private Limited Company with the name Transpact Enterprises Private Limited on May 12, 2013. Further, the status of the Company was changed to a Public Limited Company and the name of the Company was changed to Transpact Enterprises Limited and a fresh Certificate of Incorporation was granted to the Company on April 16, 2019 by the Registrar of Companies, Mumbai. The Company is the first startup to get listed on the BSE Startup Platform. It is a SINE, IIT Bombay incubated MedTech startup to provide innovative, costeffective and comprehensive solutions, products with strategic partnerships and collaborative relationships to help specially abled people to transcend their barriers. We are a design, development, manufacturing, and distribution firm for therapeutic devices and rehabilitation services with analytics and management software system. Company is an ISO 13485:2016 ISO 9001:2015 certified company for Medical Devices and quality management system.. The products include Vestibulator which is a compact, mechanized, innovative therapeutic healthcare device which is ergonomically designed to provide stimulations for vestibular, neuro developmental and sensory integration therapy. Another product is Rehabsoft which is a cloudbased therapy and rehabilitation software solution developed specifically to streamline and manage the therapy, rehab clinical documentation, nutrition schedule, administrative processes, and training and individual education plan. Apart from these, one more product includes Vestibulator Chair which is an ergonomicallydesigned compact vestibular therapy device for at home therapy of children suffering from vestibular dysfunction and developmental disorders. The chair is designed to make the inhouse therapy program more purposeful by adding more therapeutic benefit by making athome therapy repetitive, accurate and specific. Also, enabling the caretakers to give the prescribed therapy dose with a lot of ease. The Companys software solution RehabSoft, Electronic Medical Records (EMR) processing, device administration, communications and streamlines patient billing. The solution is based on Internet of Things (lOT) technologies that turns Vestibulator therapy data into electronic medical record and sends them to the private cloud, where data analytics can be performed to better evaluate patients condition. The RehabSoft improves medical care, support EMRs, enables patient data sharing among therapy centres and increases staff efficiency. The Companys integrated product offering limits the need of existing old techniques for vestibular, neurodevelopmental and sensory integration therapy. The Company constantly keeps abreast with the latest technology as per the requirement of the industry. The Company came up with a Public Issue of 1,04,000 Equity Shares by raising money from public aggregating to Rs 1.35 Crore in August, 2019.
Read More

Transpact Enterprises FAQs

You can easily buy Transpact Enterprises shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Transpact Enterprises stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -